Autor: "Cossu MV" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
Autorzy:: Cossu MV
Cattaneo D
Fucile S
Pellegrino P
Baldelli S
Cozzi V
Capetti A
Clementi E; Pokaż więcej
Temat:: Therapeutics. Pharmacology
RM1-950
Źródło:: Drug Design, Development and Therapy, Vol 2014, Iss default, Pp 411-419 (2014)
Opis pliku:: electronic resource
Relacje:: http://www.dovepress.com/combined-isosorbide-dinitrate-and-ibuprofen-as-a-novel-therapy-for-mus-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:: https://doaj.org/article/ff778377fa874022882e5b4984fd690c Link otwiera się w nowym oknie

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: PIN41 - Hepatitis C Virus: Determinants Of Patients’ Management Costs
Autorzy:: Foglia, E
Ferrario, L
Garagiola, E
Menzaghi, B
Tebini, A
Rizzardini, G
Cossu, MV
Fagiuoli, S
Pasulo, L
Colombo, M
De Nicola, S
Bruno, R
Sacchi, P
Galli, M
Croce, D; Pokaż więcej
Źródło:: In Value in Health October-November 2017 20(9):A786-A786

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study
Autorzy:: Baldin, G
Ciccullo, A
Di Giambenedetto, S
Capetti, A
Cossu, MV
Rusconi, S
Giacomelli, A
Sterrantino, G
Lagi, F
Latini, A
Bagella, P
Madeddu, G
De Luca, A; Pokaż więcej
Temat:: ANTI-HIV agents
EMTRICITABINE
COMBINATION drug therapy
HIV infections
PSYCHOLOGY of HIV-positive persons
PATIENT aftercare
LIPIDS
MEDICAL cooperation
MEDICAL practice
SCIENTIFIC observation
PATIENT safety
RESEARCH
VIRAL load
TREATMENT effectiveness
DESCRIPTIVE statistics
THERAPEUTICS
Źródło:: HIV Medicine; Feb2019, Vol. 20 Issue 2, p164-168, 5p

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?
Autorzy:: Capetti AF; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.
Atzori C; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.
Cossu MV; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.
Ciccullo A; Institute of Clinical Infectious Diseases, Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Catholic University of the Sacred Heart, Rome, Italy.
Restelli S; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.
Piscaglia M; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.
Gallazzi I; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.
Meraviglia P; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.
DiGiambenedetto S; Institute of Clinical Infectious Diseases, Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Catholic University of the Sacred Heart, Rome, Italy.
Rizzardini G; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.; Pokaż więcej
Źródło:: Open forum infectious diseases [Open Forum Infect Dis] 2019 Feb 06; Vol. 6 (2), pp. ofz044. Date of Electronic Publication: 2019 Feb 06 (Print Publication: 2019).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Morning dosing for dolutegravir-related insomnia and sleep disorders.
Autorzy:: Capetti AF; Ospedale Luigi Sacco-Polo Universitario, Milano, Lombardia, Italy.
Di Giambenedetto S; 2Â° Divisione di Malattie Infettive, UniversitÃ Cattolica del Sacro Cuore, Roma, Italy.
Latini A; Unit of Infectious Dermatology, San Gallicano Hospital, Rome, Italy.
Sterrantino G; Infectious Diseases Unit, Careggi University Hospital, Florence, Italy.
De Benedetto I; Azienda Ospedaliera San Gerardo, Monza, Lombardia, Italy.
Cossu MV; Ospedale Luigi Sacco-Polo Universitario, Milano, Lombardia, Italy.
Gori A; Azienda Ospedaliera San Gerardo, Monza, Lombardia, Italy.; Pokaż więcej
Źródło:: HIV medicine [HIV Med] 2018 May; Vol. 19 (5), pp. e62-e63. Date of Electronic Publication: 2017 Aug 01.
Typ publikacji:: Letter; Comment
MeSH Terms:: HIV Infections*
Sleep Initiation and Maintenance Disorders*
Female ; Heterocyclic Compounds, 3-Ring ; Humans ; Oxazines ; Piperazines ; Pyridones

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication.
Autorzy:: Borghetti A; Institute of Clinical Infectious Disease, Catholic University of the Sacred Heart, Rome, Italy.
Baldin G; Institute of Clinical Infectious Disease, Catholic University of the Sacred Heart, Rome, Italy.
Lombardi F; Institute of Clinical Infectious Disease, Catholic University of the Sacred Heart, Rome, Italy.
Ciccullo A; Institute of Clinical Infectious Disease, Catholic University of the Sacred Heart, Rome, Italy.
Capetti A; Division of Infectious Diseases, Department of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy.
Rusconi S; Infectious Diseases Unit, DIBIC Luigi Sacco, University of Milan, Milan, Italy.
Sterrantino G; Division of Tropical and Infectious Diseases, 'Careggi' Hospital, Florence, Italy.
Latini A; Infectious Dermatology and Allergology Unit, IFO S. Gallicano Institute (IRCCS), Rome, Italy.
Cossu MV; Division of Infectious Diseases, Department of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy.
Gagliardini R; University Division of Infectious Diseases, Siena University Hospital, Siena, Italy.
De Luca A; University Division of Infectious Diseases, Siena University Hospital, Siena, Italy.
Di Giambenedetto S; Institute of Clinical Infectious Disease, Catholic University of the Sacred Heart, Rome, Italy.; Pokaż więcej
Źródło:: HIV medicine [HIV Med] 2018 Mar 24. Date of Electronic Publication: 2018 Mar 24.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data.
Autorzy:: Capetti AF; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Via Giovanni Battista Grassi, 74, pavillion 56, Malattie Infettive, 2nd floor, 20157, Milan, Italy. .
Cossu MV; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Via Giovanni Battista Grassi, 74, pavillion 56, Malattie Infettive, 2nd floor, 20157, Milan, Italy.
Orofino G; 1st Division of Infectious Diseases Amedeo di Savoia Hospital, Torino, Italy.
Sterrantino G; Division of Infectious Diseases, 'Careggi' Hospital, Firenze, Italy.
Cenderello G; Division of Infectious Diseases, Ospedali Galliera, Genova, Italy.
De Socio GV; Infectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy.
Cattelan AM; Infectious and Tropical Diseases, Azienda Ospedaliera-Universitaria di Padova, Padova, Italy.
Soria A; Clinic of Infectious Diseases, San Gerardo Hospital, ASST Monza, University of Milano-Bicocca, Monza, Italy.
Rusconi S; Infectious Diseases Clinic, DIBIC Luigi Sacco, University of Milano, Milano, Italy.
Riccardi N; Infectious Diseases Clinic, 'San Martino' Hospital, Genova, Italy.
Baldin GM; 2nd Division of Infectious Diseases, Università Cattolica del Sacro Cuore, Rome, Italy.
Niero FP; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Via Giovanni Battista Grassi, 74, pavillion 56, Malattie Infettive, 2nd floor, 20157, Milan, Italy.
Barbarini G; 2nd Division of Infectious Diseases, 'Policlinico San Matteo' Hospital, Pavia, Italy.
Rizzardini G; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Via Giovanni Battista Grassi, 74, pavillion 56, Malattie Infettive, 2nd floor, 20157, Milan, Italy.; Whitwaterstrand University, Johannesburg, South Africa.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2017 Sep 30; Vol. 17 (1), pp. 658. Date of Electronic Publication: 2017 Sep 30.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Anti-HIV Agents/*therapeutic use
Darunavir/*therapeutic use
HIV Infections/*drug therapy
Heterocyclic Compounds, 3-Ring/*therapeutic use
Ritonavir/*therapeutic use
Drug Resistance, Viral ; Drug Therapy, Combination ; Female ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/genetics ; Humans ; Lost to Follow-Up ; Male ; Middle Aged ; Oxazines ; Piperazines ; Pyridones ; Treatment Outcome ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort.
Autorzy:: Capetti AF; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy.
Sterrantino G; Division of Infectious Diseases, 'Careggi', Hospital, Firenze, Italy.
Cossu MV; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy.
Orofino G; Division of Infectious Diseases, 'Amedeo di Savoia' Hospital, Torino, Italy.
Barbarini G; 2nd Division of Infectious Diseases, 'Policlinico San Matteo' Hospital, Pavia, Italy.
De Socio GV; Infectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy.
Di Giambenedetto S; 2nd Division of Infectious Diseases, 'Policlinico Universitario Agostino Gemelli' Hospital, Roma, Italy.
Di Biagio A; Infectious Diseases Clinic, 'San Martino' Hospital, Genova, Italy.
Celesia BM; Infectious Diseases Unit, University of Catania, ARNAS (Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione) Garibaldi, Catania, Italy.
Argenteri B; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy.
Rizzardini G; 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy.; Whitwaterstrand University, Johannesburg, South Africa.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Oct 14; Vol. 11 (10), pp. e0164753. Date of Electronic Publication: 2016 Oct 14 (Print Publication: 2016).
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: HIV Infections/*drug therapy
HIV Integrase Inhibitors/*therapeutic use
Heterocyclic Compounds, 3-Ring/*therapeutic use
Reverse Transcriptase Inhibitors/*therapeutic use
Rilpivirine/*therapeutic use
Adult ; Aged ; Antiretroviral Therapy, Highly Active ; Cohort Studies ; Creatinine/blood ; Drug Administration Schedule ; Drug Interactions ; Drug Resistance, Viral ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; HIV Infections/virology ; HIV Integrase Inhibitors/adverse effects ; HIV-1/genetics ; HIV-1/isolation & purification ; Headache/etiology ; Heterocyclic Compounds, 3-Ring/adverse effects ; Humans ; Male ; Middle Aged ; Oxazines ; Piperazines ; Pyridones ; RNA, Viral/blood ; Reverse Transcriptase Inhibitors/adverse effects ; Rilpivirine/adverse effects ; Sleep Initiation and Maintenance Disorders/etiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems.
Autorzy:: Melzi S; 1st Division of Infectious Diseases, 'Luigi Sacco' Hospital, Via GB Grassi, 74, 20157 Milan, Italy.
Carenzi L
Cossu MV
Passerini S
Capetti A
Rizzardini G; Pokaż więcej
Źródło:: Cholesterol [Cholesterol] 2010; Vol. 2010, pp. 271504. Date of Electronic Publication: 2010 Oct 31.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Cossu MV"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji